InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by SANTE HOLDINGS SRL società a responsabilità limitata (limited lability company), Directeur et représentant de Santé Holdings SRL au conseil d’administration de CARMAT. Insider active across 1 companies, notably CARMAT. Aggregated, 9 reports have been logged. Total volume traded: €936k. The latest transaction was disclosed on 4 February 2025 — Souscription. Regulator: AMF. All data is openly available.
Declarations9 total
€3m4,545,454 shares@ €0.77100.0% of flow
ActionEuronext Growth Paris
2025DD1019269·
€3m1,906,250 shares@ €1.60100.0% of flow
ActionEuronext Growth Paris
2024DD999234·
€4m1,343,333 shares@ €3.0072.9% of flow
ActionEuronext Growth Paris
2024DD967992·
€91,5587,000 shares@ €13.07970.0010% mcap7.4% of flow
ActionEuronext Paris
2024DD953626·
Ideal exit: 26 Nov 2024 (T+270)
€1m375,939 shares@ €3.9927.1% of flow
ActionEuronext Growth Paris
2024DD948708·
S
SANTE HOLDINGS SRL società a responsabilità limitata (limited liability company incorporated in Italy)board member permanently€7m1,944,442 shares@ €3.60100.0% of flow
ActionEuronext Growth Paris
2023DD934508·
€249,99738,461 shares@ €6.5020.2% of flow
Actionnewly issued shares subscribed in a capital increase
2023DD887087·
€844,360101,000 shares@ €8.360.0089% mcap68.1% of flow
ActionEuronext Paris
2022DD860615·
Ideal exit: 4 Jun 2023 (T+270)
€53,5301 shares@ €53,530.004.3% of flow
Titre de créanceHors plateforme de négociation
2022DD860616·
9 of 9 declarations
About SANTE HOLDINGS SRL società a responsabilità limitata (limited lability company)
Santé Holdings SRL is an Italian limited liability company that plays a notable governance and shareholder role at CARMAT. In market disclosures and company filings, it is identified as a long-standing reference shareholder and is described as the family office of Dr. Antonino Ligresti. Within CARMAT, the entity is represented on the board by its permanent representative, which gives it an important voice in governance, financing and capital-structure matters. CARMAT’s disclosures repeatedly list Santé Holdings SRL among its key shareholders, especially in capital increases completed in 2023, 2024 and 2025. At CARMAT, Santé Holdings SRL has acted as a stabilising investor in a highly capital-intensive medtech company. The company participated in several fundraising rounds, including sizeable cash subscriptions and commitments that helped secure the transactions. This recurring involvement shows a profile focused on long-term support for a listed healthcare company, where access to financing is critical to clinical, industrial and regulatory execution. From a governance perspective, Santé Holdings SRL appears to bring a combination of financial discipline, shareholder oversight and sector familiarity. Its presence on the board side of CARMAT is consistent with the role of a reference investor that seeks to accompany the company through dilution-sensitive equity raises, liquidity planning and strategic decision-making. The public disclosures indicate that it has been one of the historical shareholders most involved in securing the company’s financing needs, which underlines its influence in boardroom discussions on capital preservation and continuity of operations. Overall, Santé Holdings SRL should be viewed as a long-term financial and governance partner of CARMAT rather than an operating executive. Its most notable current role is as the director-representative vehicle of a reference shareholder, with a consistent presence in the company’s equity story and a strong focus on supporting growth through financing rounds.
